Kuehne+Nagel delivers first 215,000 doses of Sinovac vaccine to Ukraine
- First logistics company to deliver the Chinese Covid-19 vaccine to the Eastern European country
- Follows another Sinovac shipment to the Dominican Republic
Kuehne+Nagel has delivered a first batch of CoronaVac vaccine produced by Sinovac Biotech Ltd., a leading biopharmaceutical company in China (Nasdaq: SVA). Kuehne+Nagel therefore is the first logistics company to deliver the Chinese Covid-19 vaccine to Ukraine. The shipment is part of a global agreement between the two companies.
The first 215,000 doses of CoronaVac were delivered at the end of March 2021. The cargo was transported by air from Beijing in special active cooling containers. At all stages of transport, product integrity at the required temperature of +2 to +8°C was maintained. At the end of February, Kuehne+Nagel successfully helped Sinovac fulfill its first Covid-19 vaccine shipment to the Dominican Republic.
“Kuehne Nagel has actively expanded its GxP-certified pharma network over the past few years. We are ready to support the global fight against the pandemic by delivering medicines and vaccines as soon as possible and in compliance with the required temperature regime,” says Andrii Savka, National Air Logistics Manager, Kuehne+Nagel Ukraine.
According to the office of the President of Ukraine and the Ministry of Health, the overall contract with Sinovac Biotech encompasses 1.9 million doses of vaccine. Thus, this first delivery of CoronaVac to Ukraine just marks the start of large-scale work to overcome the pandemic in the country.
With over 78,000 employees at 1,400 locations in over 100 countries, the Kuehne+Nagel Group is one of the world's leading logistics companies. Its strong market position lies in sea logistics, air logistics, road logistics and contract logistics, with a clear focus on integrated logistics solutions.